72320
K

Krsnaa Diagnostics Ltd IPO

  • Status: Closed
  • ₹ 13,995 / 15 shares

    Minimum Investment

IPO Details

  • Open Date

    TBA

  • Close Date

    TBA

  • IPO Price Range

    ₹ 933 - 954

  • IPO Size

    ₹ ₹ 1,213.33 Cr

  • Listing Exchange

    NSE, BSE

  • Listing Date

    17 Aug 2021

With just a few clicks, Invest in IPO's!

+91

By proceeding, you agree to all T&C*

Last Updated: 14 December 2021 8:07 PM by 5Paisa

Krsnaa Diagnostics IPO Synopsis

One of the rapidly growing diagnostic chains in India, Krsnaa Diagnostics Ltd. is launching its Initial Public Offer in August 2021.

Krasnaa Diagnostics IPO will open on August 4th and closes on August 6th. With the total issue size of ₹1,213.33 Cr, the offer comprises of a fresh issue of shares worth ₹ 400 crore and an offer for sale of shares of 9,416,377 equity shares by existing selling shareholders. 

 

Krsnaa Diagnostics IPO Share holding

 

% Shareholding

Pre- IPO(%)

Promoters & Promoter Group

31.62

Public

68.38

Source: RHP

 

Object of the offer:

The company proposes to utilise the net proceeds from the issue - 
1. To finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh, and Maharashtra
2. Repayment/pre-payment of firm's borrowings fully or partially 
3. For general corporate purposes

Krsnaa Diagnostics Limited is one of the largest differentiated diagnostic service providers in India (Source: CRISIL Report). The company provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and teleradiology services to public and private hospitals, medical colleges and community health centers pan-India. Krsnaa Diagnostics operates one of India’s largest teleradiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock, 365 days a year, and allows them to serve patients in remote locations where diagnostic facilities are limited. The Company focuses on and has the largest presence in the public-private partnership (“PPP”) diagnostics segment (Source: CRISIL Report). The company provides quality and inclusive diagnostic services at affordable rates across various segments (radiology tests are priced 45% – 60% lower than market rates while pathology tests are 40% – 80% lower than market rates (Source: CRISIL Report).

Krsnaa Diagnostics has a vast network of diagnostic centres predominantly non-metro, and lower tier cities and towns in India. With 1,801 diagnostic centres in operation, Krsnaa Diagnostics offering radiology and pathology services across 13 different cities in India. 

Krsnaa Diagnostic - Financials

Particulars (in crore)

FY19

FY20

FY21

Revenue from operations

209.23

258.42

396.45

Adj. EBITDA

63.0

75.7

106.0

PAT

-58.1

-111.9

184.9

Source: RHP


Will You Apply for Krsnaa Diagnostics Ltd IPO?

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91